Because MYCN is strongly associated with progressive disease and unfavorable prognosis in high-risk NB,4 MYCN is thought to play a central role in maintaining the malignant potential of high-risk NB tumors, suggesting that MYCN is an attractive therapeutic target for the treatment of this disease.5 Here, MYCN is linked to neuroblastoma.